onCARlytics: A First-in-Class CD19-Expressing OV for Use in Solid Tumors
Time: 3:00 pm
day: Day One
Details:
- Overview of parental OV virus and clinical studies to date
- Rationale for design of onCARlytics
- Planned study design for Phase 1
